149 related articles for article (PubMed ID: 8660316)
21. Anticancer compounds and sphingolipid metabolism in the colon.
Duan RD
In Vivo; 2005; 19(1):293-300. PubMed ID: 15796189
[TBL] [Abstract][Full Text] [Related]
22. Role for matrix metalloproteinase-2 in oxidized low-density lipoprotein-induced activation of the sphingomyelin/ceramide pathway and smooth muscle cell proliferation.
Augé N; Maupas-Schwalm F; Elbaz M; Thiers JC; Waysbort A; Itohara S; Krell HW; Salvayre R; Nègre-Salvayre A
Circulation; 2004 Aug; 110(5):571-8. PubMed ID: 15277330
[TBL] [Abstract][Full Text] [Related]
23. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4.
Fischer H; Ellström P; Ekström K; Gustafsson L; Gustafsson M; Svanborg C
Cell Microbiol; 2007 May; 9(5):1239-51. PubMed ID: 17223929
[TBL] [Abstract][Full Text] [Related]
24. Apoptosis occurs via the ceramide recycling pathway in human HaCaT keratinocytes.
Takeda S; Mitsutake S; Tsuji K; Igarashi Y
J Biochem; 2006 Feb; 139(2):255-62. PubMed ID: 16452313
[TBL] [Abstract][Full Text] [Related]
25. Neutral/alkaline and acid ceramidase activities are actively released by murine endothelial cells.
Romiti E; Meacci E; Tani M; Nuti F; Farnararo M; Ito M; Bruni P
Biochem Biophys Res Commun; 2000 Sep; 275(3):746-51. PubMed ID: 10973793
[TBL] [Abstract][Full Text] [Related]
26. Effect of streptozotocin-diabetes on the functioning of the sphingomyelin-signalling pathway in skeletal muscles of the rat.
Górska M; Dobrzyń A; Zendzian-Piotrowska M; Górski J
Horm Metab Res; 2004 Jan; 36(1):14-21. PubMed ID: 14983401
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine and ceramide signalling in apoptosis.
Woodcock J
IUBMB Life; 2006 Aug; 58(8):462-6. PubMed ID: 16916783
[TBL] [Abstract][Full Text] [Related]
28. Content and structure of ceramide and sphingomyelin and sphingomyelinase activity in mouse hepatoma-22.
Rylova SN; Somova OG; Zubova ES; Dudnik LB; Kogtev LS; Kozlov AM; Alesenko AV; Dyatlovitskaya EV
Biochemistry (Mosc); 1999 Apr; 64(4):437-41. PubMed ID: 10231598
[TBL] [Abstract][Full Text] [Related]
29. Bradykinin inhibits ceramide production and activates phospholipase D in rabbit cortical collecting duct cells.
Liu G; Kleine L; Nasrallah R; Hébert RL
Am J Physiol; 1999 Apr; 276(4):F589-98. PubMed ID: 10198419
[TBL] [Abstract][Full Text] [Related]
30. Effect of hypothyreosis on the content of ceramides in rat tissues.
Górska M; Dobrzyń A; Langfort J; Górski J
J Physiol Pharmacol; 2003 Mar; 54(1):89-97. PubMed ID: 12674221
[TBL] [Abstract][Full Text] [Related]
31. Altered adipose and plasma sphingolipid metabolism in obesity: a potential mechanism for cardiovascular and metabolic risk.
Samad F; Hester KD; Yang G; Hannun YA; Bielawski J
Diabetes; 2006 Sep; 55(9):2579-87. PubMed ID: 16936207
[TBL] [Abstract][Full Text] [Related]
32. Effect of endurance training on the sphingomyelin-signalling pathway activity in the skeletal muscles of the rat.
Dobrzyń A; Zendzian-Piotrowska M; Górski J
J Physiol Pharmacol; 2004 Jun; 55(2):305-13. PubMed ID: 15213354
[TBL] [Abstract][Full Text] [Related]
33. Sphingomyelinase and cell-permeable ceramide analogs stimulate cellular proliferation in quiescent Swiss 3T3 fibroblasts.
Olivera A; Buckley NE; Spiegel S
J Biol Chem; 1992 Dec; 267(36):26121-7. PubMed ID: 1464623
[TBL] [Abstract][Full Text] [Related]
34. Effects of Chamomilla recutita flavonoids on age-related liver sphingolipid turnover in rats.
Babenko NA; Shakhova EG
Exp Gerontol; 2006 Jan; 41(1):32-9. PubMed ID: 16183236
[TBL] [Abstract][Full Text] [Related]
35. Sphingomyelin, glycosphingolipids and ceramide signalling in cells exposed to P-fimbriated Escherichia coli.
Hedlund M; Duan RD; Nilsson A; Svanborg C
Mol Microbiol; 1998 Sep; 29(5):1297-306. PubMed ID: 9767596
[TBL] [Abstract][Full Text] [Related]
36. Regulatory role of sphingomyelin metabolites in hypoxia-induced vascular smooth muscle cell proliferation.
Yun JK; Kester M
Arch Biochem Biophys; 2002 Dec; 408(1):78-86. PubMed ID: 12485605
[TBL] [Abstract][Full Text] [Related]
37. Predominance of the acylation route in the metabolic processing of exogenous sphingosine in neural and extraneural cells in culture.
Riboni L; Bassi R; Prinetti A; Viani P; Tettamanti G
Biochem J; 1999 Feb; 338 ( Pt 1)(Pt 1):147-51. PubMed ID: 9931310
[TBL] [Abstract][Full Text] [Related]
38. Analyses of the effect of monensin on glycosphingolipid metabolism.
Gundlach B; Helland R; Radsak K; Wiegandt H
Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):753-7. PubMed ID: 1953668
[TBL] [Abstract][Full Text] [Related]
39. Individual profiles of free ceramide species and the constituent ceramide species of sphingomyelin and neutral glycosphingolipid and their alteration according to the sequential changes of environmental oxygen content in human colorectal cancer Caco-2 cells.
Tanaka K; Tamiya-Koizumi K; Yamada M; Murate T; Kannagi R; Kyogashima M
Glycoconj J; 2014 Apr; 31(3):209-19. PubMed ID: 24310545
[TBL] [Abstract][Full Text] [Related]
40. Identification of a Novel Acid Sphingomyelinase Activity Associated with Recombinant Human Acid Ceramidase.
He X; Schuchman EH
Biomolecules; 2023 Nov; 13(11):. PubMed ID: 38002305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
